P.3.f.009 Prevalence of metabolic syndrome in a sample of adults with severe mental illness treated with antipsychotic medication

2015 ◽  
Vol 25 ◽  
pp. S540
Author(s):  
B. Ferreiro-Fernández ◽  
M.J. Avila González ◽  
E. Fernandez Fernandez ◽  
P. Jarazo Guerra
Keyword(s):  
Metabolic Syndrome ◽  
Mental Illness ◽  
Severe Mental Illness ◽  
Antipsychotic Medication

scholarly journals High risk of metabolic syndrome among black South African women with severe mental illness

2017 ◽  
Vol 23 ◽  
Author(s):  
Shamima Saloojee ◽  
Jonathan K. Burns ◽  
Ayesha A. Motala
Keyword(s):  
Metabolic Syndrome ◽  
Mental Illness ◽  
Severe Mental Illness ◽  
South African ◽  
Antipsychotic Medication ◽  
Matched Control ◽  
Control Group ◽  
Men And Women ◽  
Matched Control Group ◽  
Black South African

Background: There is an increased prevalence of metabolic syndrome (MetS) in individuals with severe mental illness (SMI) globally. The prevalence of MetS is higher in black women compared to black men from South Africa.Aim: To compare the prevalence of MetS between black South African men and women with SMI taking antipsychotic medication. Further, this prevalence was compared to the prevalence in a matched control group of black South African men and women without SMI. Setting: A general hospital psychiatric unit.Methods: A cross-sectional study was undertaken to compare the prevalence of MetS in a group of multi-ethnic participants with SMI treated with antipsychotic medication and a matched control group without SMI, applying the 2009 Joint Interim Statement (JIS) criteria. Here, we included only the black African participants to compare MetS prevalence between men and women.Results: There were 232 participants in the group with SMI (male 155 and female 77) and without SMI (male 156 and female 76). The prevalence of MetS was more than three times higher in women with SMI compared to men with SMI (37.7% vs. 10.3%, p < 0.001). There was no significant difference in the prevalence of MetS in men or women between the groups with and without SMI. In multivariate logistic regression analysis, female gender (odds ratio [OR] 7.66), advancing age (OR 1.08) and longer duration of illness (OR = 1.15) were significant risk factors for MetS in SMI.Conclusion: In black South Africans with SMI on antipsychotic medication, there is a higher prevalence and risk for MetS in women compared to men.

scholarly journals Metabolic syndrome in antipsychotic naive African patients with severe mental illness in usual care

2017 ◽  
Vol 12 (6) ◽  
pp. 1137-1143 ◽  
Author(s):  
Shamima Saloojee ◽  
Jonathan K. Burns ◽  
Ayesha A. Motala
Keyword(s):  
Metabolic Syndrome ◽  
Mental Illness ◽  
Severe Mental Illness ◽  
Usual Care ◽  
African Patients

Metabolic Syndrome Screening in People With Severe Mental Illness: Results From Two Spanish Community Mental Health Centers

2019 ◽  
Vol 26 (2) ◽  
pp. 162-171 ◽  
Author(s):  
Sara Fernández Guijarro ◽  
Carolina Miguel García ◽  
Edith Pomarol-Clotet ◽  
Elena Nunilón Egea López ◽  
Maria Dolors Burjales Martí ◽  
...  
Keyword(s):  
Mental Health ◽  
Risk Factors ◽  
Metabolic Syndrome ◽  
Mental Illness ◽  
Community Mental Health ◽  
Physical Health ◽  
Severe Mental Illness ◽  
Health Centers ◽  
Community Mental Health Centers ◽  
Mental Health Centers

BACKGROUND: The excess of mortality in people with severe mental illness is due to unnatural causes such as accidents or suicides and natural causes such as metabolic syndrome. The presence of modifiable risk factors like tobacco consumption increases cardiovascular and metabolic risk. AIMS: The purpose of this study was to identify the prevalence of metabolic syndrome and other cardiovascular risk factors in people with severe mental illness. This study also aimed to identify the prevalence of patients receiving treatment for any metabolic syndrome risk factor. METHOD: A cross-sectional descriptive study was performed. A total of 125 participants from two community mental health centers in Spain were recruited. RESULTS: More than half of the participants (58.4%) were active smokers. The prevalence of metabolic syndrome was 60%. A total of 16.8% received previous treatment for hypertension, 17.6% for hypertriglyceridemia, and 11.2% for diabetes. No differences were found between centers (22.7% vs. 18.7%, p = .9). CONCLUSIONS: The findings underscore the importance of monitoring the physical health of patients on antipsychotic therapy. The identification and management of cardiovascular and metabolic risks factors is an essential part of nursing care for people with severe mental illness. Mental health nurses are ideally positioned to carry out this task by performing physical health screening, health education, and lifestyle interventions.

scholarly journals What is the experience of registered nurses in assessing people with severe mental illness for metabolic syndrome?

2021 ◽  
Vol 21 (8) ◽  
pp. 477-484
Author(s):  
Ruth Crawford ◽  
Sisilia Finau Peini ◽  
Teramira Christine Schutz
Keyword(s):  
Mental Health ◽  
Metabolic Syndrome ◽  
Mental Illness ◽  
Mental Health Services ◽  
Health Services ◽  
Severe Mental Illness ◽  
Registered Nurses ◽  
Face To Face ◽  
Mental Health Settings ◽  
One Stop

Introduction: Metabolic Syndrome is a prevalent condition in New Zealand and worldwide, affecting adult populations, especially those who are in long-term  antipsychotic medications for severe mental illness. Registered nurses play a crucial role in improving the health of this population. Methods: Five registered nurses with at least two years of working experience in the mental health settings participated in this qualitative, exploratory study, underpinned by the Kakala Research Framework. Semi-structured face-to-face interviews with the participants were undertaken to gather research data and thematic analysis was used to find common themes. Findings: Registered nurses in mental health services are experiencing clinical and professional enablers as well as professional, organisational and systematic barriers in assessing people with severe mental illness for metabolic syndrome. Conclusion: Skilled registered nurses in mental health services are required to take the responsibility for providing a “one-stop-shop” for people with metabolic syndrome.

scholarly journals Do financial incentives increase treatment adherence in people with severe mental illness? A systematic review

2010 ◽  
Vol 19 (3) ◽  
pp. 233-242 ◽  
Author(s):  
Alexandra Burton ◽  
Stamatina Marougka ◽  
Stefan Priebe
Keyword(s):  
Systematic Review ◽  
Mental Illness ◽  
Severe Mental Illness ◽  
Treatment Adherence ◽  
Antipsychotic Medication ◽  
Financial Incentives ◽  
Psychiatric Treatment ◽  
Focus Group Study ◽  
Improve Treatment ◽  
Severely Mentally Ill

SUMMARYAim – To identify whether financial or material incentives improve treatment adherence in people with severe mental illness. Method – A systematic review of studies published between 1950 and 2008 was conducted. EMBASE, MEDLINE, EBM, AMED and PsycINFO were searched. Studies were included if a financial or material incentive was offered and if the sample had a severe mental illness. Results – Fourteen articles were identified; three studies on adherence to psychiatric treatment and one on physical exercise. Ten articles used incentives for adherence to substance misuse treatment programmes. In all studies, financial incentives were associated with an increase in adherence; however the effect was not always maintained once the incentive was withdrawn. Conclusion – While existing research suggests that financial incentives may improve treatment adherence in severely mentally ill populations, very few studies focus on psychiatric treatment. Further research may address the long term effectiveness of incentives on adherence in this population.Declaration of Interest: The authors on this paper were supported by funds from the Wellcome Trust. All authors worked on a Wellcome Trust funded qualitative focus group study exploring stakeholder views on offering patients financial incentives to adhere to antipsychotic medication. Priebe is also lead applicant on a National Institute of Health Research (England) (NIHR) awarded grant to conduct a clinical trial on the use of financial incentives to achieve maintenance antipsychotic medication adherence.

Sign in / Sign up

Export Citation Format

Share Document